SCHEMBL6172296

SCHEMBL6172296

Cc1cccc(C(=O)c2cc3cc(Cl)ccc3[nH]2)c1

nearest known ligand 0.72

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.72
KMT2A Q03164 3/20 0.72
NPC1 O15118 2/20 0.72
RAB9A P51151 2/20 0.72
CLK1 P49759 1/20 0.57
DYRK1A Q13627 1/20 0.57
BCAT1 P54687 1/20 0.57
FLT3 P36888 3/20 0.56
F7 P08709 1/20 0.56
F3 P13726 1/20 0.56
PDGFRB P09619 2/20 0.55
PDGFRA P16234 1/20 0.55
NHERF1 O14745 2/20 0.53
CYP1A2 P05177 1/20 0.50
CYP3A4 P08684 1/20 0.50
CYP2C9 P11712 1/20 0.50
TSHR P16473 1/20 0.50
HDAC6 Q9UBN7 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6170060 0.89 MEN1 (0.57) MEN1KMT2ANPC1RAB9ACLK1
SCHEMBL6170838 0.89 MEN1 (0.81) MEN1KMT2ANPC1RAB9ACLK1
SCHEMBL6407379 0.85 BCAT1 (0.67) MEN1KMT2ANPC1RAB9ABCAT1
SCHEMBL10227495 0.83 PDGFRB (0.68) MEN1KMT2ANPC1RAB9ACLK1
SCHEMBL6169285 0.82 RAB9A (0.65) MEN1KMT2ANPC1RAB9AFLT3
SCHEMBL6171445 0.82 MEN1 (0.76) MEN1KMT2ANPC1RAB9AFLT3
SCHEMBL6168411 0.81 MEN1 (0.82) MEN1KMT2ANPC1RAB9ACLK1
SCHEMBL6403700 0.81 BCAT1 (0.62) MEN1KMT2ANPC1RAB9ABCAT1
SCHEMBL6173193 0.78 MEN1 (0.64) MEN1KMT2ANPC1RAB9ACLK1
SCHEMBL6172428 0.77 MEN1 (0.62) MEN1KMT2ANPC1RAB9ACLK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1045833-B1 2,3-SUBSTITUTED INDOLE COMPOUNDS AS COX-2 INHIBITORS PFIZER (US) 2005-11-02 EP disclosed
US-6608070-B1 Useful for treatment of medical condition in which prostaglandins are implicated as pathogens NAKAO KAZUNARI (JP) 2003-08-19 US disclosed
CN-1284064-A 2,3-substituted indole compounds as cox-2 inhibitors PFIZER PHARMA (US) 2001-02-14 CN disclosed
EP-1045833-A1 2,3-SUBSTITUTED INDOLE COMPOUNDS AS COX-2 INHIBITORS PFIZER INC. (US) 2000-10-25 EP disclosed
WO-1999035130-A1 2,3-SUBSTITUTED INDOLE COMPOUNDS AS COX-2 INHIBITORS PFIZER PHARMACEUTICALS INC. (JP) 1999-07-15 WO disclosed